{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:55:49Z","timestamp":1783918549061,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI) are at increased risk for contrast-induced nephropathy (CIN) than elective PCI procedures. Routine calculation of Mehran\u2019s score is limited by its complexity and difficulty to memorize. This study evaluated CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score predictive utility for CIN in STEMI patients before pPCI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Consecutive 500 acute STEMI patients presenting to two Egyptian pPCI centers were recruited. Exclusion criteria included cardiogenic shock or known severe renal impairment (baseline serum creatinine\u2009\u2265\u20093\u00a0mg\/dL) or current or previous indication of hemodialysis. CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VAS<jats:sub>C<\/jats:sub> score<jats:sub>,<\/jats:sub> Mehran\u2019s score, baseline estimated glomerular filtration rate (eGFR), contrast media volume (CMV) and CMV\/eGFR ratio were collected for all patients. Post-pPCI CIN (defined as 0.5\u00a0mg\/dL absolute increase or 25% relative increase of serum creatinine from baseline) and predictive accuracy of CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VAS<jats:sub>C<\/jats:sub> and Mehran\u2019s scores were evaluated. CIN occurred in 35 (7%) of the study group. Values of CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VAS<jats:sub>C<\/jats:sub> score<jats:sub>,<\/jats:sub> Mehran\u2019s score, baseline eGFR, CMV and CMV\/eGFR ratio were significantly higher in those who developed CIN compared to those who did not. CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VAS<jats:sub>C<\/jats:sub> score<jats:sub>,<\/jats:sub> Mehran\u2019s score and CMV\/eGFR were found to be independent predictors for CIN (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001 for all). ROC curve analysis revealed that CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VAS<jats:sub>C<\/jats:sub>\u2009\u2265\u20094 had a superb predictive ability, comparable to Mehran\u2019s score, for post-pPCI CIN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Being practical, easily memorizable and applicable before proceeding to pPCI, routine CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VAS<jats:sub>C<\/jats:sub> score calculation in STEMI patients can effectively predict CIN risk and guide preventive and\/or therapeutic interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-023-00378-x","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T08:03:07Z","timestamp":1687766587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictive value of CHA2DS2VASC score for contrast-induced nephropathy after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction"],"prefix":"10.1186","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-4976","authenticated-orcid":false,"given":"Ahmad","family":"Samir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafik","family":"Gabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Alhossary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Bakhoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"issue":"3","key":"378_CR1","first-page":"357","volume":"3","author":"PA McCullough","year":"2014","unstructured":"McCullough PA (2014) Contrast-induced nephropathy. Definitions, epidemiology, and implications. Interv Cardiol Clin. 3(3):357\u2013362","journal-title":"Interv Cardiol Clin."},{"issue":"908","key":"378_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1259\/bjr\/26964464","volume":"76","author":"HS Thomsen","year":"2003","unstructured":"Thomsen HS, Morcos SK (2003) Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76(908):513\u2013518","journal-title":"Br J Radiol"},{"issue":"12","key":"378_CR3","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","volume":"21","author":"F Stacul","year":"2011","unstructured":"Stacul F, Van Der Molen AJ, Reimer P, Webb JAW, Thomsen HS, Morcos SK, Alm\u00e9n T, Aspelin P, Bellin MF, Clement O, Heinz-Peer G (2011) Contrast induced nephropathy: Updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21(12):2527\u20132541","journal-title":"Eur Radiol"},{"issue":"3","key":"378_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/1995-705X.125926","volume":"14","author":"NM Mohammed","year":"2013","unstructured":"Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R (2013) Contrast-induced nephropathy. Heart Views. 14(3):106","journal-title":"Heart Views."},{"issue":"7","key":"378_CR5","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44(7):1393\u20131399","journal-title":"J Am Coll Cardiol"},{"key":"378_CR6","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno HHH, Caforio ALPP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk\u00fd P, Baumbach A, Bugiardini R, Coman IM, Delgado V, Fitzsimons D, Gaemperli O, Gershlick AH, Gielen S, Harjola VPP, Katus HA, Knuuti J, Kolh P, Leclercq C, Lip GYHH, Morais J, Neskovic AN, Neumann FJJ, Niessner A, Piepoli MF, Richter DJ, Shlyakhto E, Simpson IA, Steg PG, Terkelsen CJ, Thygesen K, Windecker S, Zamorano JL, Zeymer U, Chettibi M, Hayrapetyan HG, Metzler B, Ibrahimov F, Sujayeva V, Beauloye C, Dizdarevic-Hudic L, Karamfiloff K, Skoric B, Antoniades L, Tousek P, Shaheen SM, Marandi T, Niemel\u20aca M, Kedev S, Gilard M, Aladashvili A, Elsaesser A, Kanakakis IG, Merkely BB, Gudnason T, Iakobishvili Z, Bolognese L, Berkinbayev S, Bajraktari G, Beishenkulov M, Zake I, Lamin H Ben, Gustiene O, Pereira B, Xuereb RG, Ztot S, Julieb\u00f8 V, Legutko J, Timoteo AT, Tatu-Chit\u00b8oiu G, Yakovlev A, Bertelli L, Nedeljkovic M, Studencan M, Bunc M, de Castro AMG, Petursson P, Jeger R, Mourali MS, Yildirir A, Parkhomenko A, Gale CP, Terkelsen CJ, Shaheen SM, Marandi T, Niemel\u20aca M, Kedev S, Gilard M, Aladashvili A, Elsaesser A, Kanakakis IG, Merkely BB, Gudnason T, Iakobishvili Z, Bolognese L, Berkinbayev S, Bajraktari G, Beishenkulov M, Zake I, Lamin H Ben, Gustiene O, Pereira B, Xuereb RG, Ztot S, Julieb\u00f8 V, Legutko J, Timoteo AT, Tatu-Chit\u00b8oiu G, Yakovlev A, Bertelli L, Nedeljkovic M, Studencan M, Bunc M, de Castro AMG, Petursson P, Jeger R, Mourali MS, Yildirir A, Parkhomenko A, Gale CP, Collet JP, Kristensen SD, Aboyans V, Baumbach A, Bugiardini R, Coman IM, Delgado V, Fitzsimons D, Gaemperli O, Gershlick AH, Gielen S, Harjola VPP, Katus HA, Knuuti J, Kolh P, Leclercq C, Lip GYHH, Morais J, Neskovic AN, Neumann FJJ, Niessner A, Piepoli MF, Richter DJ, Shlyakhto E, Simpson IA, Steg PG, Terkelsen CJ, Thygesen K, Windecker S, Zamorano JL, Zeymer U, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno HHH, Coca A, Collet JP, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, J\u00fcni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh T, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Zamorano JL, Chettibi M, Hayrapetyan HG, Metzler B, Ibrahimov F, Sujayeva V, Beauloye C, Dizdarevic-Hudic L, Karamfiloff K, Skoric B, Antoniades L, Tousek P, Terkelsen PJ, Shaheen SM, Marandi T, Niemel\u00e4 M, Kedev S, Gilard M, Aladashvili A, Elsaesser A, Kanakakis IG, Merkely BB, Gudnason T, Iakobishvili Z, Bolognese L, Berkinbayev S, Bajraktari G, Beishenkulov M, Zake I, Lamin H Ben, Gustiene O, Pereira B, Xuereb RG, Ztot S, Julieb\u00f8 V, Legutko J, Tim\u00f3teo AT, Tatu-Chi\u0163oiu G, Yakovlev A, Bertelli L, Nedeljkovic M, Studen\u010dan M, Bunc M, Garc\u00eda de Castro AM, Petursson P, Jeger R, Mourali MS, Yildirir A, Parkhomenko A, Gale CP (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39(2):119\u2013177","DOI":"10.1093\/eurheartj\/ehx393"},{"issue":"12","key":"378_CR7","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.amjcard.2004.03.008","volume":"93","author":"BA Bartholomew","year":"2004","unstructured":"Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O\u2019Neill WW (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93(12):1515\u20131519","journal-title":"Am J Cardiol"},{"issue":"2","key":"378_CR8","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(2):e21-129","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"378_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/2048872616673536","volume":"7","author":"F Guerra","year":"2018","unstructured":"Guerra F, Scappini L, Maolo A, Campo G, Pavasini R, Shkoza M, Capucci A (2018) CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 7(3):264\u2013274","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"3","key":"378_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/clc.23147","volume":"42","author":"F Vitali","year":"2019","unstructured":"Vitali F, Serenelli M, Airaksinen J, Pavasini R, Tomaszuk-Kazberuk A, Mlodawska E, Jaakkola S, Balla C, Falsetti L, Tarquinio N, Ferrari R, Squeri A, Campo G, Bertini M (2019) CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta-analysis. Clin Cardiol 42(3):358\u2013364","journal-title":"Clin Cardiol"},{"issue":"7","key":"378_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s11739-021-02799-5","volume":"16","author":"C Goudis","year":"2021","unstructured":"Goudis C, Daios S, Korantzopoulos P, Liu T (2021) Does CHA2DS2-VASc score predict mortality in chronic kidney disease? Intern Emerg Med 16(7):1737\u20131742","journal-title":"Intern Emerg Med"},{"key":"378_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40256-019-00365-1","volume":"20","author":"Y Rezaei","year":"2020","unstructured":"Rezaei Y, Peighambari MM, Naghshbandi S, Samiei N, Ghavidel AA, Dehghani MR, Haghjoo M, Hosseini S (2020) Postoperative atrial fibrillation following cardiac surgery: from pathogenesis to potential therapies. Am J Cardiovasc Drugs 20:19\u201349","journal-title":"Am J Cardiovasc Drugs"},{"key":"378_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Corbett S, Chettibi M, Hayrapetyan H, Roithinger FX, Aliyev F, Sujayeva V, Claeys MJ, Smaji\u0107 E, Kala P, Iversen KK, El HE, Marandi T, Porela P, Antov S, Gilard M, Blankenberg S, Davlouros P, Gudnason T, Alcalai R, Colivicchi F, Elezi S, Baitova G, Zakke I, Gustiene O, Beissel J, Dingli P, Grosu A, Damman P, Juliebo V, Legutko J, Morais J, Tatu-Chitoiu G, Yakovlev A, Zavatta M, Nedeljkovic M, Radsel P, Sionis A, Jemberg T, M\u00fcller C, Abid L, Abaci A, Parkhomenko A (2018) Fourth universal definition of myocardial infarction. Circulation 138:618\u2013651","journal-title":"Circulation"},{"issue":"3","key":"378_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","volume":"99","author":"AK Cheung","year":"2021","unstructured":"Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, Knoll GA, Muntner P, Pecoits-Filho R, Sarnak MJ, Tobe SW, Tomson CRV, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Mann JFE (2021) Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int 99(3):559\u2013569","journal-title":"Kidney Int"},{"issue":"4","key":"378_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, Kusek JW, van Lente F (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med [Internet] 145(4):247\u2013254. https:\/\/doi.org\/10.7326\/0003-4819-145-4-200608150-00004","journal-title":"Ann Intern Med [Internet]"},{"issue":"39","key":"378_CR16","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1093\/eurheartj\/ehz687","volume":"40","author":"PJ Grant","year":"2019","unstructured":"Grant PJ, Cosentino F (2019) The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 40(39):3215\u20133217","journal-title":"Eur Heart J"},{"issue":"10","key":"378_CR17","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.jacc.2003.07.012","volume":"42","author":"RH Mehta","year":"2003","unstructured":"Mehta RH, Harjai KJ, Cox D, Stone GW, Brodie B, Boura J, O\u2019Neill W, Grines CL (2003) Clinical and angiographic correlates and outcomes of suboptimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol 42(10):1739\u20131746","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"378_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW, With C, Surgeons T, January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW (2019) 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol 74(1):104\u2013132","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"378_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, Kirchhof P, K\u00fchne M, Aboyans V, Ahlsson A, Balsam P, Bauersachs J, Benussi S, Brandes A, Braunschweig F, Camm AJ, Capodanno D, Casadei B, Conen D, Crijns HJGM, Delgado V, Dobrev D, Drexel H, Eckardt L, Fitzsimons D, Folliguet T, Gale CP, Gorenek B, Haeusler KG, Heidbuchel H, Iung B, Katus HA, Kotecha D, Landmesser U, Leclercq C, Lewis BS, Mascherbauer J, Merino JL, Merkely B, Mont L, Mueller C, Nagy KV, Oldgren J, Pavlovi\u0107 N, Pedretti RFE, Petersen SE, Piccini JP, Popescu BA, P\u00fcrerfellner H, Richter DJ, Roffi M, Rubboli A, Scherr D, Schnabel RB, Simpson IA, Shlyakhto E, Sinner MF, Steffel J, Sousa-Uva M, Suwalski P, Svetlosak M, Touyz RM, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Neil Thomas G, Valgimigli M, Van Gelder IC, Watkins CL, Delassi T, Sisakian HS, Scherr D, Chasnoits A, De PM, Smaji\u0107 E, Shalganov T, Avraamides P, Kautzner J, Gerdes C, Alaziz AA, Kampus P, Raatikainen P, Boveda S, Papiashvili G, Eckardt L, Vassilikos V, Csan\u00e1di Z, Arnar DO, Galvin J, Barsheshet A, Caldarola P, Rakisheva A, Byty\u00e7i I, Kerimkulova A, Kalejs O, Njeim M, Puodziukynas A, Groben L, Sammut MA, Grosu A, Boskovic A, Moustaghfir A, de Groot N, Poposka L, Anfinsen OG, Mitkowski PP, Cavaco DM, Siliste C, Mikhaylov EN, Bertelli L, Kojic D, Hatala R, Fras Z, Arribas F, Juhlin T, Sticherling C, Abid L, Atar I, Sychov O, Bates MGD, Zakirov NU (2021) Corrigendum to 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European 1. Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"19","key":"378_CR20","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","volume":"105","author":"CS Rihal","year":"2002","unstructured":"Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105(19):2259\u20132264","journal-title":"Circulation"},{"issue":"2","key":"378_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0002-9343(83)90618-6","volume":"74","author":"SH Hou","year":"1983","unstructured":"Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT (1983) Hospital-acquired renal insufficiency: a prospective study. Am J Med 74(2):243\u2013248","journal-title":"Am J Med"},{"issue":"5","key":"378_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","volume":"103","author":"PA McCullough","year":"1997","unstructured":"McCullough PA, Wolyn R, Rocher LL, Levin RN, O\u2019Neill WW (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103(5):368\u2013375","journal-title":"Am J Med"},{"issue":"1","key":"378_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","volume":"95","author":"G Dangas","year":"2005","unstructured":"Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95(1):13\u201319","journal-title":"Am J Cardiol"},{"issue":"8","key":"378_CR24","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s003300050894","volume":"9","author":"SK Morcos","year":"1999","unstructured":"Morcos SK, Thomsen HS, Webb JAW (1999) Contrast-media-induced nephrotoxicity: a consensus report. Eur Radiol 9(8):1602\u20131613","journal-title":"Eur Radiol"},{"issue":"5","key":"378_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0002-9343(90)90180-L","volume":"89","author":"CL Manske","year":"1990","unstructured":"Manske CL, Sprafka JM, Strony JT, Wang Y (1990) Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89(5):615\u2013620","journal-title":"Am J Med"},{"issue":"2","key":"378_CR26","first-page":"93","volume":"36","author":"G Deray","year":"1991","unstructured":"Deray G, Baumelou B, Martinez F, Brillet G, Jacobs C (1991) Renal vasoconstriction after low and high osmolar contrast agents in ischemic and non ischemic canine kidney. Clin Nephrol 36(2):93\u201396","journal-title":"Clin Nephrol"},{"issue":"8","key":"378_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/00004424-200208000-00003","volume":"37","author":"I Hizoh","year":"2002","unstructured":"Hizoh I, Haller C (2002) Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol 37(8):428\u2013434","journal-title":"Invest Radiol"},{"issue":"20","key":"378_CR28","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehn197","volume":"29","author":"G Romano","year":"2008","unstructured":"Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, Colombo A, Condorelli G (2008) Contrast agents and renal cell apoptosis. Eur Heart J 29(20):2569\u20132576","journal-title":"Eur Heart J"},{"issue":"1","key":"378_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/ajkd.1998.v32.pm9669426","volume":"32","author":"RE Katholi","year":"1998","unstructured":"Katholi RE, Woods WT, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, McCann WP (1998) Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 32(1):64\u201371","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"378_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00134-017-4700-9","volume":"43","author":"S Ehrmann","year":"2017","unstructured":"Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS (2017) Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med 43(6):785\u2013794","journal-title":"Intensive Care Med"},{"key":"378_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.12659\/MSM.912569","volume":"25","author":"B Liao","year":"2019","unstructured":"Liao B, Nian W, Xi A, Zheng M (2019) Evaluation of a diagnostic test of serum neutrophil gelatinase-associated lipocalin (NGAL) and urine KIM-1 in contrast-induced nephropathy (CIN). Med Sci Monit 25:565\u2013570","journal-title":"Med Sci Monit"},{"issue":"4","key":"378_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1177\/0192623312464122","volume":"41","author":"RL Rouse","year":"2013","unstructured":"Rouse RL, Stewart SR, Thompson KL, Zhang J (2013) Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media. Toxicol Pathol 41(4):662\u2013680","journal-title":"Toxicol Pathol"},{"issue":"4","key":"378_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/CIRCINTERVENTIONS.109.910638","volume":"3","author":"JR Brown","year":"2010","unstructured":"Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O\u2019Connor GT, Solomon RJ, Malenka DJ (2010) Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 3(4):346\u2013350","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"378_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43044-023-00357-2","volume":"75","author":"A Samir","year":"2023","unstructured":"Samir A, Almahjori M, Zarif B, Elshinawi M, Yehia H, Elhafy M, Shehata A, Farrag A (2023) Characterization of features and outcomes of young patients (< 45 years) presenting with ST-segment elevation myocardial infarction. Egypt Heart J 75(1):32. https:\/\/doi.org\/10.1186\/s43044-023-00357-2","journal-title":"Egypt Heart J"},{"issue":"9","key":"378_CR35","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jacc.2005.01.041","volume":"45","author":"A Halkin","year":"2005","unstructured":"Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, Cox DA, Turco M, Stuckey TD, Na Y, Lansky AJ, Gersh BJ, O\u2019Neill WW, Mehran R, Stone GW (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45(9):1397\u20131405","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"378_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12872-021-01978-8","volume":"21","author":"Y Fu","year":"2021","unstructured":"Fu Y, Pan Y, Gao Y, Yang X, Chen M (2021) Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction. BMC Cardiovasc Disord 21(1):175","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"378_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.amjcard.2019.05.036","volume":"124","author":"H Peng","year":"2019","unstructured":"Peng H, Sun Z, Chen H, Zhang Y, Ding X, Zhao XQ, Li H (2019) Usefulness of the CHA2DS2-VASc score to predict adverse outcomes in acute coronary syndrome patients without atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 124(4):476\u2013484","journal-title":"Am J Cardiol"},{"issue":"1","key":"378_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MCA.0000000000000781","volume":"31","author":"HA Barman","year":"2020","unstructured":"Barman HA, Kahyaoglu S, Durmaz E, Atici A, Gulsen K, Tugrul S, Isleyen HB, Yildirim MR, Gungor B, Okuyan E, Sahin I (2020) The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction. Coron Artery Dis 31(1):7\u201312","journal-title":"Coron Artery Dis"},{"key":"378_CR39","doi-asserted-by":"crossref","unstructured":"Ashoori A, Pourhosseini H, Ghodsi S, Salarifar M, Nematipour E, Alidoosti M, Haji-Zeinali AM, Nozari Y, Amirzadegan A, Aghajani H, Jalali A, Hosseini Z, Jenab Y, Geraiely B, Omidi N (2019) CHA2DS2-VASc score as an independent predictor of suboptimal reperfusion and short-term mortality after primary PCI in patients with acute ST segment elevation myocardial infarction. Medicina (Kaunas) 55(2)","DOI":"10.3390\/medicina55020035"},{"issue":"4","key":"378_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ihj.2019.09.005","volume":"71","author":"AK Chaudhary","year":"2019","unstructured":"Chaudhary AK, Pathak V, Kunal S, Shukla S, Pathak P (2019) CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome. Indian Heart J 71(4):303\u2013308","journal-title":"Indian Heart J"},{"issue":"6","key":"378_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.amjcard.2016.11.033","volume":"119","author":"A Kurtul","year":"2017","unstructured":"Kurtul A, Yarlioglues M, Duran M (2017) Predictive value of CHA2DS2-VASC score for contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 119(6):819\u2013825","journal-title":"Am J Cardiol"},{"issue":"14","key":"378_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Bauersachs J, Dendale P, Edvardsen T, Gale CP, Jobs A, Lambrinou E, Mehilli J, Merkely B, Roffi M, Sibbing D, Kastrati A, Mamas MA, Aboyans V, Angiolillo DJ, Bueno H, Bugiardini R, Byrne RA, Castelletti S, Chieffo A, Cornelissen V, Crea F, Delgado V, Drexel H, Gierlotka M, Halvorsen S, Haugaa KH, Jankowska EA, Katus HA, Kinnaird T, Kluin J, Kunadian V, Landmesser U, Leclercq C, Lettino M, Meinila L, Mylotte D, Ndrepepa G, Omerovic E, Pedretti RFE, Petersen SE, Petronio AS, Pontone G, Popescu BA, Potpara T, Ray KK, Luciano F, Richter DJ, Shlyakhto E, Simpson IA, Sousa-Uva M, Storey RF, Touyz RM, Valgimigli M, Vranckx P, Yeh RW, Barth\u00e9l\u00e9my O, Bhatt DL, Dorobantu M, Folliguet T, Gilard M, J\u00fcni P, Lewis BS, Meliga E, Mueller C, Rutten FH, Siontis GCM (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289\u20131367","journal-title":"Eur Heart J"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00378-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-023-00378-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00378-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:20:11Z","timestamp":1687810811000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-023-00378-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1186\/s43044-023-00378-x","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol\u00a0and the informed consent form\u00a0were revised and\u00a0approved\u00a0by\u00a0the research ethics committee, Faculty of Medicine, Cairo University under registration number (MS-238-2020) [Research ethics committee reference:\u2009+0201201730249;\u00a0kasralainyrec@gmail.com]. Written informed consents were acquired from all study participants. This study is registered on clinicaltrials.gov [NCT04730778].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient informed consent form included approval to publish anonymized clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have competing or conflicting interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}